main-logo

ICD-10 Code D81.3 | Adenosine deaminase [ADA] deficiency Symptoms, Diagnosis, Billing

Adenosine deaminase (ADA) deficiency is a rare genetic disorder that leads to severe combined immunodeficiency (SCID). It is caused by mutations in the ADA gene, resulting in the accumulation of toxic metabolites that impair lymphocyte function. Accurate coding with ICD-10 Code D81.3 is essential for proper diagnosis, documentation, and billing, facilitating appropriate patient management and public health reporting.

What is ICD-10 Code D81.3 for Adenosine deaminase [ADA] deficiency?

ICD-10 Code D81.3 represents Adenosine deaminase (ADA) deficiency, a genetic disorder characterized by the absence or deficiency of the ADA enzyme. This condition leads to immunodeficiency, making patients susceptible to infections. The code should be used in clinical documentation and billing when diagnosing patients with confirmed ADA deficiency, ensuring accurate representation of the patient's health status.

ICD-10 Code D81.3 – Clinical Definition and Explanation of Adenosine deaminase [ADA] deficiency

Adenosine deaminase (ADA) deficiency is caused by mutations in the ADA gene, leading to the accumulation of toxic metabolites that adversely affect lymphocyte development and function. This condition progresses rapidly, resulting in severe immunodeficiency that necessitates immediate medical intervention.

Key Clinical Features:

  • Severe recurrent infections due to immunodeficiency.
  • Failure to thrive in infants and young children.
  • Lymphopenia and low levels of T and B lymphocytes.
  • Potential for life-threatening complications without treatment.

ICD-10 Code D81.3 for Adenosine deaminase [ADA] deficiency – SOAP Notes & Clinical Use

ICD-10 Code D81.3 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of patients with ADA deficiency. It plays a crucial role in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and guiding clinical decision-making.

What Does ICD-10 Code D81.3 for Adenosine deaminase [ADA] deficiency Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D81.3 connects subjective patient reports and objective clinical findings to a formal diagnosis of ADA deficiency. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code D81.3 – Adenosine deaminase [ADA] deficiency

Adenosine deaminase deficiency requires urgent medical attention, often necessitating hospitalization for management.

Antibiotic Therapy:

  • Not applicable as ADA deficiency is not an infectious condition; however, prophylactic antibiotics may be used to prevent infections.
  • Consideration of antiviral therapy in cases of viral infections.
  • Supportive care may include immunoglobulin replacement therapy.

Supportive Care:

  • Immediate isolation to prevent exposure to infections.
  • Immunoglobulin replacement therapy to boost immune function.
  • Potential hematopoietic stem cell transplantation for long-term management.

Infection Control:

  • Strict hand hygiene protocols.
  • Use of masks and protective equipment in healthcare settings.
  • Avoidance of live vaccines and exposure to infectious agents.

How to Document Symptoms of Adenosine deaminase [ADA] deficiency (ICD-10 D81.3) in SOAP Notes

Subjective:

  • Patient reports recurrent infections, including pneumonia and otitis media.
  • History of failure to thrive and poor weight gain.
  • Family history of immunodeficiency disorders.
  • Patient expresses concern about frequent hospital visits.

Objective:

  • Vital signs: elevated heart rate, low-grade fever.
  • Laboratory findings: lymphopenia with low T and B cell counts.
  • Physical examination: signs of malnutrition and recurrent infections.
  • Imaging studies may show signs of pneumonia or other infections.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Adenosine deaminase [ADA] deficiency (ICD-10 Code D81.3)

Assessment:

  • Diagnosis: Adenosine deaminase deficiency (ICD-10 D81.3), severe immunodeficiency.
  • Severity: Classified as severe due to recurrent infections and lymphopenia.
  • Triggers: Genetic mutations leading to enzyme deficiency.
  • Complications: Risk of life-threatening infections.

Plan:

  • Initiate immunoglobulin replacement therapy.
  • Consider referral for hematopoietic stem cell transplantation.
  • Educate family on infection prevention strategies.
  • Schedule follow-up appointments for monitoring and management.

Treatment & Plan Section for ICD-10 Code D81.3 – Adenosine deaminase [ADA] deficiency

  • First-line treatment includes immunoglobulin replacement therapy.
  • Consider hematopoietic stem cell transplantation for definitive treatment.
  • Educate patients on avoiding infections and recognizing symptoms.
  • Regular monitoring of immune function and infection status.

Using ICD-10 Code D81.3 for Adenosine deaminase [ADA] deficiency in Billing & SOAP Note Compliance

  • Ensure accurate documentation of symptoms and clinical findings in SOAP notes.
  • Use D81.3 in conjunction with other relevant codes for comprehensive billing.
  • Align treatment plans with clinical guidelines to support justified billing.
  • Document any complications or comorbidities to enhance coding accuracy.

ICD-10 Code D81.3 in Medical Billing and Insurance for Adenosine deaminase [ADA] deficiency

ICD-10 Code D81.3 is critical in medical billing, particularly in hospital and infectious disease care settings.

Billing Notes:

  • Document all relevant clinical findings and patient history to support the use of D81.3.
  • Use this code in inpatient settings to reflect the severity of the condition.
  • Ensure that all chart elements align with the diagnosis for accurate claims processing.

Common CPT Pairings:

CPT CodeDescription
36415Collection of venous blood by venipuncture.
90715Immunization administration for immunoglobulin therapy.
38220Bone marrow aspiration and/or biopsy.

Frequently Asked Questions

Common Questions About Using ICD-10 Code D81.3 for Adenosine deaminase [ADA] deficiency

What are the common symptoms of Adenosine deaminase deficiency?

Common symptoms include recurrent infections, failure to thrive, and lymphopenia. Patients may experience severe respiratory infections and other opportunistic infections due to compromised immune function.

How is Adenosine deaminase deficiency treated?

Treatment typically involves immunoglobulin replacement therapy and may include hematopoietic stem cell transplantation for a definitive cure. Supportive care is crucial to manage infections.

Is Adenosine deaminase deficiency hereditary?

Yes, Adenosine deaminase deficiency is an autosomal recessive genetic disorder, meaning both parents must carry the mutated gene for a child to be affected.

What is the prognosis for patients with Adenosine deaminase deficiency?

Without treatment, the prognosis is poor due to severe immunodeficiency. However, with appropriate management, including stem cell transplantation, patients can lead healthier lives.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved